This January, 100+ world-leading specialists in spatial biology will come together in San Diego for the premier industry-led event dedicated to showcasing the real-world applications of spatial proteomics and transcriptomics in unravelling tissue complexity.
The 3rd Spatial Biology for Immuno-Oncology Summit has a packed agenda that will unite pharma, biotech, and solution providers to focus on a field that is advancing at an unprecedented speed.
Program Director Hope Kent (pictured) said: “As spatial biology develops, it’s important to discuss how we can make this area more effective and cost-efficient.
“With expert speakers from Abbvie, Pfizer, Johnson & Johnson Innovative Medicine, Genentech, Amgen, and more, this event is an exclusive opportunity to refine gold-standard methodologies for practical applications in immuno-oncology drug development.”
Attendees will hear exclusive talks from Eli Lilly & Co. and Takeda, on ‘Effective Communication of Data Analysis in Spatial Omics’ and ‘Decoding Tumor Microenvironments: Using Spatial Omics for Discovering New Biomarkers’, as well as fresh data readouts presented by Gilead, Repare Therapeutics and Bristol Myers Squibb.
Aside from the content itself, the conference has been designed to allow attendees to connect with one another.
Previous attendees, such as representatives from MEI Pharma and Arcus Biosciences, agreed the summit includes a ‘tremendous amount of interaction and engagement’ and ‘great opportunities for networking.’
Across the wide and ever-growing field of spatial biology, attendees will have the chance to share their work and build strong relationships with their peers.
Passes for drug developers are also free for 2025.
For more information on the full agenda, visit: https://ter.li/spatial-biology-immuno-oncology-event-guide
